85888 Federal Register / Vol. 88, No. 236 / Monday, December 11, 2023 / Notices 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Characteristics of Cases of Priority 

Fungal Diseases (OMB Control No. 

0920–1385, Exp. 3/31/2026)— 

Revision—National Center for Emerging 

and Zoonotic Infectious Diseases 

(NCEZID), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Fungal diseases cause substantial 

illness, ranging from mild infection to 

severe or life-threatening invasive 

disease. They also constitute a 

considerable financial burden on 

patients and healthcare systems. 

Awareness of fungal diseases is low, 

and data collection has historically been 

limited in size, scope, and coordination, 

which has hindered our understanding 

of these diseases. Detailed 

epidemiologic and clinical data are 

critical to inform appropriate public 

health responses. 

We plan to enhance surveillance of 

high priority fungal diseases across the 

United States to better characterize 

factors such as disease burden, 

geographic scope, patient risk factors, 

health disparities, healthcare utilization, 

outcomes, and emerging trends. This 

project will serve as a Revision of the 

information collections project: 

Triazole-resistant Aspergillus fumigatus 

Case Report Form (CRF). The Revision 

will expand the number of fungal 

diseases for which data may be 

collected. In addition to triazoleresistant A. fumigatus infections, CRFs 

have also been developed for 

coccidioidomycosis, histoplasmosis, 

blastomycosis, C. auris, and antifungalresistant dermatophytosis. CDC is also 

changing the name of this information 

collections project from Triazoleresistant Aspergillus fumigatus Case 

Report Form to Characteristics of Cases 

of Priority Fungal Diseases. 

We plan to use standardized CRFs to 

collect public health surveillance data 

for cases of these diseases regarding 

demographics (e.g., age, sex, race/ 

ethnicity, location of residence), 

underlying medical conditions, 

diagnosis (e.g., clinical presentation, 

laboratory testing), treatments, and 

outcomes (e.g., hospitalization, vital 

status). The corresponding CRF would 

be filled out voluntarily by State and 

local health departments and contains a 

section for medical chart review and an 

optional supplemental interview 

(including data on potential 

occupational or environmental 

exposures) of the patient or their 

representative. Findings can help 

identify populations at higher risk of 

these diseases, detect emerging 

epidemiologic trends, and guide 

prevention and response efforts. They 

can also help better focus public and 

healthcare provider outreach, inform 

efforts to contain or mitigate spread, and 

influence health policy and research on 

prevention and treatment. 

CDC requests OMB approval for an 

estimated 1,138 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

State and Local Health Departments Characteristics of Patients with Environmentally-derived Triazole-resistant Aspergillus fumigatus.15 15 30/60 113 

State and Local Health Departments Characteristics of Patients with Coccidioidomycosis.10 25 1 250 

State and Local Health Departments Characteristics of Patients with 

Histoplasmosis.

10 25 1 250 

State and Local Health Departments Characteristics of Patients with Blastomycosis.10 25 1 250 

State and Local Health Departments Characteristics of Patients with Candida 

auris.

15 20 45/60 225 

State and Local Health Departments Characteristics of Patients with Antifungal-resistant Dermatophytosis.10 10 30/60 50 

Total ............................................ ........................................................................ .................... ........................ .................... 1,138 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–27081 Filed 12–8–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–24BJ; Docket No. CDC–2023– 

0097] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled DP–23–0002 

Healthy Schools Evaluation. The project 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 236 / Monday, December 11, 2023 / Notices 85889 

aims to evaluate processes and 

outcomes of the programs of 20 State 

entities funded by CDC’s Healthy 

Schools Branch to improve health, 

academic achievement, and well-being 

of students in K–12 schools nationwide. 

DATES: CDC must receive written 

comments on or before February 9, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0097 by either of the following methods: 

b Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

b Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329; Telephone: 404–639– 

7118; Email: omb@cdc.gov. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

CDC–RFA–DP–23–0002 Healthy 

Schools Program Evaluation—New— 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

CDC awarded funds through 

cooperative agreement DP23–0002 (2302 

Program) to 20 funding recipients 

(States, universities, and a Tribal nation) 

to improve health, academic 

achievement, and well-being of students 

in K–12 schools. A portion of the 

funding within each State is allocated to 

one priority local education agency 

(LEA) and its corresponding schools to 

support the implementation of policies, 

practices, and programs to increase 

physical activity, healthy dietary 

behaviors, and management of chronic 

health conditions among students. CDC 

is conducting a mixed-methods multilevel evaluation of the 2302 Program 

and associated outcomes. Evaluation 

findings will allow CDC to help 

recipients improve their programs as 

they progress over the five-year funding 

period. A CDC evaluation contractor 

will collect information from relevant 

funded recipients, priority LEAs, 

schools, and students. Program 

monitoring information will be 

collected from recipients via a monthly 

reporting tool. Descriptions of the 

implementation of the program’s two 

strategies and nine activities will be 

collected in years two and four via semistructured, virtual key informant 

interviews with program leaders among 

funded recipients and their priority LEA 

colleagues to understand successes, 

barriers, and lessons learned. 

Additionally, two annual questionnaires 

will be distributed either digitally (webbased) and/or on paper. One of the 

questionnaires is for school-level 

leaders in participating schools in the 

20 priority LEAs focusing on 

implementation of healthy school 

policies, practices, and programs. The 

other questionnaire is for students in 

elementary, middle, and high schools 

(grades 4–12) in the priority LEAs’ 

schools focusing on physical activity, 

dietary behaviors, management of 

chronic health conditions, and wellbeing and academic attainment. The 

evaluation results will help recipients 

improve their programs and aid CDC in 

understanding and communicating the 

impact of its funding. We 

CDC requests approval for the period 

of three years, with an anticipated 

request for an extension after that to 

cover the full five years of the program. 

The annual estimated total time burden 

to participants is 810 hours. There are 

no anticipated financial costs to 

participants other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

Recipient personnel ................................. Recipient Monthly Reporting ................... 20 12 15/60 60 

Recipient and priority LEA personnel ...... Interviews ................................................ 60 1 40/60 40 

School personnel ..................................... Healthy Schools Survey .......................... 100 1 30/60 50 

Students ................................................... Healthy Students Survey ......................... 2,000 1 20/60 660 

Total .................................................. .................................................................. .................... ........................ .................... 810 


lotter on DSK11XQN23PROD with NOTICES1
85890 Federal Register / Vol. 88, No. 236 / Monday, December 11, 2023 / Notices 

1https://www.whitehouse.gov/briefing-room/ 

presidential-actions/2021/01/20/executive-orderadvancing-racial-equity-and-support-forunderserved-communities-through-the-federalgovernment/. 

2Assistant Secretary for Planning and Evaluation. 

(2021, December). Methods and Emerging Strategies 

to Engage People with Lived Experience. (Contract 

Number HHSP233201500071I). U.S. Department of 

Health and Human Services. https://aspe.hhs.gov/ 

sites/default/files/documents/47f62cae9671

0d1fa13b0f590f2d1b03/lived-experience-brief.pdf. 

3https://www.whitehouse.gov/briefing-room/ 

presidential-actions/2023/02/16/executive-orderon-further-advancing-racial-equity-and-support-forunderserved-communities-through-the-federalgovernment/. 

4https://www.whitehouse.gov/briefing-room/ 

presidential-actions/2021/01/27/memorandum-onrestoring-trust-in-government-through-scientificintegrity-and-evidence-based-policymaking/. 

5https://www.hhs.gov/about/strategic-plan/2022- 

2026/index.html. 

6https://www.acf.hhs.gov/about/acf-strategicplan-2022. 

7https://www.acf.hhs.gov/opre/report/acfevaluation-policy. 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–27080 Filed 12–8–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C. 1009(d), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–OH–23–003, Panel A, 

Occupational Safety and Health 

Education and Research Centers (ERC). 

Dates: February 26–27, 2024. 

Times: 11 a.m.–5 p.m., EST. 

Place: Video-Assisted Meeting. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Michael Goldcamp, Ph.D., Scientific 

Review Officer, Office of Extramural 

Programs, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1095 Willowdale Road, Morgantown, 

West Virginia 26505. Telephone: (304) 

285–5951; Email: MGoldcamp@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–27206 Filed 12–7–23; 1:00 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Administration for Children 

and Families Generic for Engagement 

Efforts (New Umbrella Generic) 

AGENCY: Administration for Children 

and Families, United States Department 

of Health and Human Services. 

ACTION: Request for public comments. 

SUMMARY: The Administration for 

Children and Families (ACF) at the 

United States Department of Health and 

Human Services (HHS) intends to 

request approval from the Office of 

Management and Budget (OMB) to 

establish a new umbrella generic 

clearance to request information while 

engaging individuals and groups who 

could provide valuable information to 

inform ACF programs and work, 

including but not limited to those who 

are served or have been served by ACF, 

those with expertise in ACF program 

areas, and individuals invested in the 

outcomes of ACF research and 

evaluation. These engagement activities 

often need to be conducted quickly, to 

allow for sufficient time to inform 

project direction and decision-making. 

Additionally, planning for engagement 

activities is most often on a quick 

timeline and the standard timeline to 

comply with a full request under the 

Paperwork Reduction Act (PRA) often 

inhibits the ability to collect 

information to inform these activities. 

Therefore, an umbrella generic is 

necessary to allow for quick turnaround 

requests for similar information 

collections related to these activities. 

DATES: Comments due within 60 days of 

publication. In compliance with the 

requirements of the Paperwork 

Reduction Act of 1995, ACF is soliciting 

public comment on the specific aspects 

of the information collection described 

above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The Executive Order 

(E.O.), Advancing Racial Equity and 

Support for Underserved Communities 

Through the Federal Government (E.O. 

13985) 1 emphasizes consulting with 

communities that have been historically 

underserved by Federal policies and 

programs and those with lived 

experience 2 in ACF programs. The E.O. 

on Further Advancing Racial Equity and 

Support for Underserved Communities 

Through the Federal Government 3

followed in 2023 and built on E.O. 

13985, calling upon agencies to increase 

engagement with underserved 

communities and to ‘‘collaborate with 

OMB, as appropriate, to identify and 

develop tools and methods’’ to meet this 

goal. This generic mechanism is a tool 

that could directly address these EOs. 

Particularly many requirements 

outlined in Sec 3 and Sec 5 of the 2023 

E.O. 

Additionally, the Presidential 

Memorandum on Restoring Trust in 

Government through Scientific Integrity 

and Evidence-Based Policy Making,4 the 

Department of Health and Human 

Services (HHS) Strategic Plan FY 2022– 

2026,5 ACF’s Strategic Plan,6 and the 

ACF Evaluation Policy 7 discuss 

community engagement and inclusion 

in research. Consistent with these 

guidance documents, and to ensure 

meaningful involvement with a variety 

of individuals with diverse experiences 

and perspectives, ACF often conducts 

active engagement activities to inform 

various efforts, including research and 

evaluation. 

Hearing the perspective of those 

affected by, experienced in, interested 


lotter on DSK11XQN23PROD with NOTICES1